Virtu Financial’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3,155
| Closed | -$338K | – | 1725 |
|
|
2024
Q4 | $338K | Buy |
+3,155
| New | +$338K | 0.02% | 646 |
|
|
2023
Q3 | – | Sell |
-2,945
| Closed | -$212K | – | 1620 |
|
|
2023
Q2 | $212K | Buy |
+2,945
| New | +$212K | 0.02% | 782 |
|
|
2020
Q4 | – | Sell |
-6,135
| Closed | -$365K | – | 1624 |
|
|
2020
Q3 | $365K | Buy |
6,135
+783
| +15% | +$46.6K | 0.06% | 369 |
|
|
2020
Q2 | $373K | Buy |
+5,352
| New | +$373K | 0.04% | 471 |
|
|
2019
Q4 | $286K | Buy |
4,403
+820
| +23% | +$53.3K | 0.03% | 708 |
|
|
2019
Q3 | $222K | Buy |
+3,583
| New | +$222K | 0.02% | 910 |
|
|
2019
Q2 | – | Sell |
-5,497
| Closed | -$431K | – | 1658 |
|
|
2019
Q1 | $431K | Buy |
5,497
+2,988
| +119% | +$234K | 0.02% | 621 |
|
|
2018
Q4 | $212K | Buy |
2,509
+536
| +27% | +$45.3K | 0.01% | 917 |
|
|
2018
Q3 | $338K | Buy |
+1,973
| New | +$338K | 0.02% | 784 |
|
|
2018
Q1 | – | Sell |
-3,562
| Closed | -$304K | – | 2298 |
|
|
2017
Q4 | $304K | Sell |
3,562
-5,921
| -62% | -$505K | 0.02% | 1258 |
|
|
2017
Q3 | $805K | Buy |
+9,483
| New | +$805K | 0.04% | 570 |
|